FATE,Fate Therapeutics, Inc. | Healthcare

Healthcare

FATE

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Fate Therapeutics, Inc.FATE

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide.

Its chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma and FT522, to treat lymphoma and autoimmune disorders; and CAR T-cell programs include FT819 to treat hematologic malignancies and solid tumors, and FT825 to treat solid tumors.

The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of cancer.

Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Latest News >

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Standex International Insider Sold Shares Worth $584,405, According to a Recent SEC Filing

Aug 7, 2025

02:18 PM EDT, 08/07/2025 (MT Newswires) -- Ademir Sarcevic, Vice President, CFO, Treasurer, on August 06, 2025, sold 3,047 shares in Standex International ( SXI ) for $584,405. Following the Form 4 filing with the SEC, Sarcevic has control over a total of 11,323 common shares of the company, with 11,323 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/310354/000112760225020214/xslF345X05/form4.xml Price: 192.19, Change:...

A O Smith Insider Sold Shares Worth $1,241,953, According to a Recent SEC Filing

Aug 7, 2025

02:20 PM EDT, 08/07/2025 (MT Newswires) -- James F Stern, Executive Vice President, General Counsel & Secretary, on August 07, 2025, sold 17,434 shares in A O Smith ( AOS ) for $1,241,953. Following the Form 4 filing with the SEC, Stern has control over a total of 98,784 common shares of the company, with 98,784 shares held directly. SEC...

Sunrun Shares Rise After Q2 Net Income, Revenue Beat Expectations

Aug 7, 2025

02:19 PM EDT, 08/07/2025 (MT Newswires) -- Sunrun ( RUN ) shares were up more than 29% in recent Thursday trading after the company reported late Wednesday Q2 earnings and revenue that increased year-over-year and beat analyst expectations. The energy service company reported Q2 net income of $1.07 per diluted share, up from $0.55 a year earlier. Analysts polled by...